{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:09:08Z","timestamp":1790874548363,"version":"4.1.0"},"reference-count":44,"publisher":"The Endocrine Society","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,7,1]]},"DOI":"10.1210\/jc.2008-2742","type":"journal-article","created":{"date-parts":[[2009,4,7]],"date-time":"2009-04-07T22:05:00Z","timestamp":1239141900000},"page":"2255-2261","source":"Crossref","is-referenced-by-count":129,"title":["Effect of Surgery on Cardiovascular Risk Factors in Mild Primary Hyperparathyroidism"],"prefix":"10.1210","volume":"94","author":[{"given":"Jens","family":"Bollerslev","sequence":"first","affiliation":[{"name":"Section of Endocrinology (J.B., G.A.I., K.G., T.U.), Department of Medicine, Rikshospitalet, Oslo University Hospital, and University of Oslo, 0027 Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thord","family":"Rosen","sequence":"additional","affiliation":[{"name":"Department of Endocrinology (T.R., C.F.), Sahlgrenska Hospital, S-41685 Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte L.","family":"Mollerup","sequence":"additional","affiliation":[{"name":"Department of Endocrine Surgery (C.L.M.), Copenhagen University Hospital, DK-2100 Rikshospitalet, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u0308rgen","family":"Nordenstro\u0308m","sequence":"additional","affiliation":[{"name":"Department of Breast and Endocrine Surgery (J.N.), Karolinska University Hospital, SE-17176 Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Baranowski","sequence":"additional","affiliation":[{"name":"Department of Medicine (M.B.), St. Olav\u2019s Hospital, University of Trondheim, 7006 Trondheim, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celina","family":"Franco","sequence":"additional","affiliation":[{"name":"Department of Endocrinology (T.R., C.F.), Sahlgrenska Hospital, S-41685 Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ylva","family":"Pernow","sequence":"additional","affiliation":[{"name":"Department of Endocrinology (Y.P.), Karolinska University Hospital, SE-17176 Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunhild A.","family":"Isaksen","sequence":"additional","affiliation":[{"name":"Section of Endocrinology (J.B., G.A.I., K.G., T.U.), Department of Medicine, Rikshospitalet, Oslo University Hospital, and University of Oslo, 0027 Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Godang","sequence":"additional","affiliation":[{"name":"Section of Endocrinology (J.B., G.A.I., K.G., T.U.), Department of Medicine, Rikshospitalet, Oslo University Hospital, and University of Oslo, 0027 Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thor","family":"Ueland","sequence":"additional","affiliation":[{"name":"Section of Endocrinology (J.B., G.A.I., K.G., T.U.), Department of Medicine, Rikshospitalet, Oslo University Hospital, and University of Oslo, 0027 Oslo, Norway"},{"name":"Research Institute for Internal Medicine (T.U.), University of Oslo, 0027 Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svante","family":"Jansson","sequence":"additional","affiliation":[{"name":"Department of Surgery (S.J.), Sahlgrenska Hospital, S-41685 Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the SIPH Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041113465892100_R1","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1359\/JBMR.050910","article-title":"Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993\u20132001: an update on the changing epidemiology of the disease.","volume":"21","author":"Wermers","year":"2006","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041113465892100_R2","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0002-9343(97)00270-2","article-title":"Survival after the diagnosis of hyperparathyroidism: a population-based study.","volume":"104","author":"Wermers","year":"1998","journal-title":"Am J Med"},{"key":"key\n\t\t\t\t2019041113465892100_R3","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/ncpendmet0265","article-title":"The diagnosis and management of asymptomatic primary hyperparathyroidism.","volume":"2","author":"Silverberg","year":"2006","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113465892100_R4","doi-asserted-by":"crossref","first-page":"5353","DOI":"10.1210\/jc.2002-021370","article-title":"Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century.","volume":"87","author":"Bilezikian","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113465892100_R5","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1136\/bmj.317.7162.848","article-title":"Population based case-control study of sick leave in postmenopausal women before diagnosis of hyperparathyroidism.","volume":"317","author":"Lundgren","year":"1998","journal-title":"BMJ"},{"key":"key\n\t\t\t\t2019041113465892100_R6","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1210\/jc.2007-0600","article-title":"Disturbances of calcium homeostasis consistent with mild primary hyperparathyroidism in premenopausal women and associated morbidity.","volume":"93","author":"Siilin","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113465892100_R7","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1210\/jc.2004-1891","article-title":"Association between primary hyperparathyroidism and increased body weight: a meta-analysis.","volume":"90","author":"Bolland","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113465892100_R8","first-page":"2149","article-title":"Serum calcium and survival in a large health screening program.","volume":"81","author":"Leifsson","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113465892100_R9","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s00268-002-6541-z","article-title":"Cardiovascular events before and after surgery for primary hyperparathyroidism.","volume":"27","author":"Vestergaard","year":"2003","journal-title":"World J Surg"},{"key":"key\n\t\t\t\t2019041113465892100_R10","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/bmj.327.7414.530","article-title":"Cohort study on effects of parathyroid surgery on multiple outcomes in primary hyperparathyroidism.","volume":"327","author":"Vestergaard","year":"2003","journal-title":"BMJ"},{"key":"key\n\t\t\t\t2019041113465892100_R11","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.surg.2005.02.001","article-title":"Maintained normalization of cardiovascular dysfunction 5 years after parathyroidectomy in primary hyperparathyroidism.","volume":"137","author":"Nilsson","year":"2005","journal-title":"Surgery"},{"key":"key\n\t\t\t\t2019041113465892100_R12","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/BF02509549","article-title":"Endothelin concentrations are elevated in plasma of patients with primary and secondary hyperparathyroidism.","volume":"58","author":"Lakatos","year":"1996","journal-title":"Calcif Tissue Int"},{"key":"key\n\t\t\t\t2019041113465892100_R13","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1067\/msy.2099.101422","article-title":"Endothelial vasodilatory dysfunction in primary hyperparathyroidism is reversed after parathyroidectomy.","volume":"126","author":"Nilsson","year":"1999","journal-title":"Surgery"},{"key":"key\n\t\t\t\t2019041113465892100_R14","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11914-008-0014-8","article-title":"Parathyroid hormone and the cardiovascular system.","volume":"6","author":"Fitzpatrick","year":"2008","journal-title":"Curr Osteoporos Rep"},{"key":"key\n\t\t\t\t2019041113465892100_R15","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1046\/j.0300-0664.2001.01468.x","article-title":"Normalized dyslipidaemia after parathyroidectomy in mild primary hyperparathyroidism: population-based study over five years.","volume":"56","author":"Hagstrom","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113465892100_R16","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1530\/eje.1.02173","article-title":"Metabolic abnormalities in patients with normocalcemic hyperparathyroidism detected at a population-based screening.","volume":"155","author":"Hagstro\u0308m","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041113465892100_R17","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/j.ehj.2003.07.005","article-title":"N-terminal pro-brain natriuretic peptide. A new gold standard in predicting mortality in patients with advanced heart failure.","volume":"24","author":"Gardner","year":"2003","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t2019041113465892100_R18","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1056\/NEJMoa031994","article-title":"Plasma natriuretic peptide levels and the risk of cardiovascular events and death.","volume":"350","author":"Wang","year":"2004","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113465892100_R19","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1365-2265.2005.02363.x","article-title":"Increased plasma N-terminal pro-B-type natriuretic peptide and markers of inflammation related to atherosclerosis in patients with primary hyperparathyroidism.","volume":"63","author":"Ogard","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113465892100_R20","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1210\/jc.2004-1400","article-title":"Arterial stiffness in mild primary hyperparathyroidism.","volume":"90","author":"Rubin","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113465892100_R21","doi-asserted-by":"crossref","first-page":"4260","DOI":"10.1210\/jc.2005-2825","article-title":"Changes in insulin sensitivity and glucose and bone metabolism over time in patients with asymptomatic primary hyperparathyroidism.","volume":"91","author":"Ayturk","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113465892100_R22","doi-asserted-by":"crossref","first-page":"593","DOI":"10.7326\/0003-4819-114-7-593","volume":"114","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t2019041113465892100_R23","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1210\/jc.2006-1836","article-title":"Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial.","volume":"92","author":"Bollerslev","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113465892100_R24","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1002\/jbmr.5650091002","article-title":"Universal standardization for dual x-ray absorptiometry: patient and phantom cross-calibration results.","volume":"9","author":"Genant","year":"1994","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041113465892100_R25","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1530\/eje.1.02125","article-title":"Positive effects of a physiological dose of GH on markers of atherogenesis: a placebo-controlled study in patients with adult-onset GH deficiency.","volume":"154","author":"Bollerslev","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041113465892100_R26","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/8756-3282(86)90020-7","article-title":"Trabecular bone remodeling and balance in primary hyperparathyroidism.","volume":"7","author":"Eriksen","year":"1986","journal-title":"Bone"},{"key":"key\n\t\t\t\t2019041113465892100_R27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2265.2007.03162.x","article-title":"Primary hyperparathyroidism and the skeleton.","volume":"69","author":"Mosekilde","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113465892100_R28","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/8756-3282(92)90360-9","article-title":"Primary hyperparathyroidism: iliac crest trabecular bone volume, structure, remodeling, and balance evaluated by histomorphometric methods.","volume":"13","author":"Christiansen","year":"1992","journal-title":"Bone"},{"key":"key\n\t\t\t\t2019041113465892100_R29","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0169-6009(08)80100-6","article-title":"Bone histomorphometry and serum concentrations of intact parathyroid hormone (PTH(1\u201384)) in patients with primary hyperparathyroidism.","volume":"23","author":"Doorn","year":"1993","journal-title":"Bone Miner"},{"key":"key\n\t\t\t\t2019041113465892100_R30","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1210\/jc.2005-2102","article-title":"Effect of primary hyperparathyroidism on volumetric bone mineral density and bone geometry assessed by peripheral quantitative computed tomography in postmenopausal women.","volume":"91","author":"Charopoulos","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113465892100_R31","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S8756-3282(99)00207-0","article-title":"Primary hyperparathyroidism: effect of parathyroidectomy on regional bone mineral density in Danish patients: a three-year follow-up study.","volume":"25","author":"Christiansen","year":"1999","journal-title":"Bone"},{"key":"key\n\t\t\t\t2019041113465892100_R32","first-page":"1562","article-title":"On the mechanism of cancellous bone preservation in postmenopausal women with mild primary hyperparathyroidism.","volume":"84","author":"Dempster","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113465892100_R33","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.bone.2007.03.020","article-title":"Preserved three-dimensional cancellous bone structure in mild primary hyperparathyroidism.","volume":"41","author":"Dempster","year":"2007","journal-title":"Bone"},{"key":"key\n\t\t\t\t2019041113465892100_R34","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1210\/jcem-70-4-930","article-title":"The histomorphometry of bone in primary hyperparathyroidism: preservation of cancellous bone structure.","volume":"70","author":"Parisien","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113465892100_R35","first-page":"863","article-title":"Seventeen year follow-up study of bone mass in patients with mild asymptomatic hyperparathyroidism some of whom were operated on.","volume":"161","author":"Elvius","year":"1995","journal-title":"Eur J Surg"},{"key":"key\n\t\t\t\t2019041113465892100_R36","doi-asserted-by":"crossref","first-page":"5415","DOI":"10.1210\/jc.2004-0028","article-title":"Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism.","volume":"89","author":"Rao","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113465892100_R37","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1056\/NEJM199910213411701","article-title":"A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery.","volume":"341","author":"Silverberg","year":"1999","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113465892100_R38","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1210\/jc.2007-1215","article-title":"The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years.","volume":"93","author":"Rubin","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113465892100_R39","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1210\/edrv.22.4.0437","article-title":"Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications.","volume":"22","author":"Lips","year":"2001","journal-title":"Endocr Rev"},{"key":"key\n\t\t\t\t2019041113465892100_R40","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1365-2265.2005.02371.x","article-title":"Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism.","volume":"63","author":"Moosgaard","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"Suppl 2","key":"key\n\t\t\t\t2019041113465892100_R41","doi-asserted-by":"crossref","first-page":"V100","DOI":"10.1359\/jbmr.07s202","article-title":"Vitamin D deficiency and primary hyperparathyroidism","volume":"22","author":"Silverberg","year":"2007","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041113465892100_R42","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s00415-005-0027-5","article-title":"Neuropsychological function in relation to serum parathyroid hormone and serum 25-hydroxyvitamin D levels. The Tromso study.","volume":"253","author":"Jorde","year":"2006","journal-title":"J Neurol"},{"key":"key\n\t\t\t\t2019041113465892100_R43","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1055\/s-2006-925135","article-title":"Biochemical markers of endothelial activation in primary hyperparathyroidism.","volume":"38","author":"Fallo","year":"2006","journal-title":"Horm Metab Res"},{"key":"key\n\t\t\t\t2019041113465892100_R44","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.metabol.2006.08.019","article-title":"Circulating leptin and adiponectin levels in patients with primary hyperparathyroidism.","volume":"56","author":"Delfini","year":"2007","journal-title":"Metabolism"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/94\/7\/2255\/9063288\/jcem2255.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T06:38:42Z","timestamp":1589697522000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/94\/7\/2255\/2596389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,1]]},"references-count":44,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,7,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2008-2742","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,1]]}}}